CD86 and Hepatic fibrosis: Then we analyzed the number of CD86+ and CD206+ macrophages in liver tissues and found that GFAPMyD88−/− mice exhibited a reduction in the M1-like phenotype and an increase in the M2-like phenotype compared to that in control mice with liver fibrosis (Fig. 6a).